 CAMBRIDGE, Mass. and EMERYVILLE, Calif., Dec. 3, 2020 PRNewswire -- Tevard Biosciences, a privately-held biotechnology company pioneering tRNA-based gene therapies, and Zogenix Nasdaq: ZGNX, a global biopharmaceutical company developing and commercializing rare disease therapies,... 